Cheshire, United Kingdom

Jonathan Gawn


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jonathan Gawn

Introduction: Jonathan Gawn, an accomplished inventor based in Cheshire, GB, has made significant strides in the field of eukaryotic expression systems. With one patent to his name, Gawn's work focuses primarily on enhancing gene expression in various cell types, showcasing his dedication to advancing biotechnological innovations.

Latest Patents: Gawn’s notable patent, titled "Vectors comprising guinea pig CMV regulatory elements," encompasses novel polynucleotides and related vectors, host cells, methods, and compositions. This invention introduces transcriptional enhancers that provide exceptionally high levels of expression for operably-linked expressible nucleic acid sequences in eukaryotic cells. Notably, these enhancers can be utilized alongside their naturally-associated promoters and other genetic elements that promote increased transcription. Gawn's eukaryotic expression vectors offer superior expression levels compared to traditional human or murine CMV IE enhancer/promoter elements, marking a significant advancement in the field.

Career Highlights: Jonathan Gawn is currently associated with Millipore Corporation, where his groundbreaking work continues to push boundaries in genetic research and biotechnology. His innovative approaches to gene expression not only provide new tools for researchers but also hold the potential for developing therapeutic applications.

Collaborations: Throughout his career, Gawn has had the privilege of collaborating with esteemed colleagues such as Steven Geraint Williams and Alistair Simpson Irvine. These collaborative efforts have fostered a rich exchange of ideas and accelerated advancements in their shared fields of study.

Conclusion: Jonathan Gawn's inventive spirit and commitment to innovation have produced impactful advancements in eukaryotic expression technologies. His work stands as a testament to the potential of scientific inquiry to drive progress in biotechnology, and his continued collaborations promise to yield even further achievements in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…